Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.27 - $2.6 $23,063 - $47,216
18,160 New
18,160 $24,000
Q1 2023

May 15, 2023

BUY
$1.17 - $2.7 $12,402 - $28,620
10,600 Added 51.81%
31,060 $56,000
Q3 2022

Nov 16, 2022

BUY
$3.14 - $4.87 $9,420 - $14,610
3,000 Added 17.18%
20,460 $68,000
Q1 2022

May 24, 2022

BUY
$4.66 - $7.66 $81,363 - $133,743
17,460 New
17,460 $89,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $197M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track M Holdings Securities, Inc. Portfolio

Follow M Holdings Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on M Holdings Securities, Inc. with notifications on news.